Strategies in Chronic Myeloid Leukemia: The Evolving Treatment Landscape
0 Views
administrator
07/08/23
Earn CME for related activities: https://hmpeducation.com/
This webcast features a presentation by Dr. Gabriella Hobbs that examines the most recent evidence-based guidelines to optimize individualized tyrosine kinase inhibitor (TKI) selection for chronic myeloid leukemia (CML) patients based on disease phase, treatment history, genetic mutation profile, and comorbidities,
-
Category
Show more
Facebook Comments
No comments found